Aprea Therapeutics raised €5.0M in a Series C round in Jan 2019. The company is based in Stockholm, Sweden. Investors in the round: Janus Henderson Investors. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €5.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
